SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-030945
Filing Date
2019-08-09
Accepted
2019-08-08 18:25:33
Documents
63
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q arna-10q_20190630.htm   iXBRL 10-Q 2447233
2 EX-10.3 arna-ex103_147.htm EX-10.3 32469
3 EX-10.4 arna-ex104_146.htm EX-10.4 30468
4 EX-31.1 arna-ex311_9.htm EX-31.1 15032
5 EX-31.2 arna-ex312_8.htm EX-31.2 15410
6 EX-32.1 arna-ex321_7.htm EX-32.1 8792
7 GRAPHIC ghf1aba4ob40000001.jpg GRAPHIC 111930
  Complete submission text file 0001564590-19-030945.txt   8413451

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA arna-20190630.xsd EX-101.SCH 45891
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE arna-20190630_cal.xml EX-101.CAL 64253
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE arna-20190630_def.xml EX-101.DEF 158737
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE arna-20190630_lab.xml EX-101.LAB 387524
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE arna-20190630_pre.xml EX-101.PRE 280919
13 EXTRACTED XBRL INSTANCE DOCUMENT arna-10q_20190630_htm.xml XML 1664237
Mailing Address 6154 NANCY RIDGE DRIVE SAN DIEGO CA 92121
Business Address 6154 NANCY RIDGE DRIVE SAN DIEGO CA 92121 858-453-7200
ARENA PHARMACEUTICALS INC (Filer) CIK: 0001080709 (see all company filings)

IRS No.: 232908305 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-31161 | Film No.: 191010894
SIC: 2834 Pharmaceutical Preparations